BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel
5 results:

  • 1. METTL3 restrains papillary thyroid cancer progression via m
    He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
    Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
    Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
    Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.